original ) (raw )Dihydro-beta-agarofuran sesquiterpenes: a new class of reversal agents of the multidrug resistance phenotype mediated by P-glycoprotein in the protozoan parasite Leishmania
Ángel Ravelo , Mercedes Campillo
Current pharmaceutical design, 2005
View PDFchevron_right
Dihidro-β-Agarofuran Sesquiterpenes: A New Class of Reversal Agents of the Multidrug Resistance Phenotype Mediated by P-Glycoprotein in the Protozoan Parasite Leishmania
FERNANDO CORTES
Current Pharmaceutical Design, 2005
View PDFchevron_right
Dihidro-β-agarofuran sesquiterpenes : A new class of reversal agents of the multidrug resistance phenotype mediated by P-glycoprotein in the protozoan parasite Leishmania : Treatment of infectious diseases and drug resistance
Mercedes Campillo
Current Pharmaceutical Design, 2005
View PDFchevron_right
Functional expression of a multidrug P-glycoprotein transporter of Leishmania
Attila Iliás
Biochemical and Biophysical Research Communications, 2005
View PDFchevron_right
Alkyl-Lysophospholipid Resistance in Multidrug-Resistant Leishmania tropica and Chemosensitization by a Novel P-Glycoprotein-Like Transporter Modulator
Adriana Parodi
Antimicrobial Agents and Chemotherapy, 2001
View PDFchevron_right
Sensitivity of Leishmania spp. to Glibenclamide and 4-Aminopiridine: A Tool for the Study of Drug Resistance Development
Alicia Ponte
Memórias do Instituto Oswaldo Cruz, 1997
View PDFchevron_right
Drug resistance in Leishmania: similarities and differences to other organisms
christoph kundig
Drug Resistance Updates, 1998
View PDFchevron_right
ChemInform Abstract: Leishmania Cell Wall as a Potent Target for Antiparasitic Drugs. A Focus on the Glycoconjugates
Franck Daligault
ChemInform, 2015
View PDFchevron_right
Altered Drug Membrane Permeability in a Multidrug-Resistant Leishmania tropica Line
José Pérez-victoria , Raimundo Del Moral
Biochemical Pharmacology, 1998
View PDFchevron_right
Leishmania amazonensis: Metabolic adaptations induced by resistance to an ABC transporter blocker
Adriana Gamboa Rodriguez
Experimental Parasitology, 2006
View PDFchevron_right
Molecular pharmacology of chemo-resistant Leishmania
Nirsen Garcia
2012
View PDFchevron_right
P-glycoprotein A Gene Expression in Glucantime-Resistant and Sensitive Leishmania major (MRHO/IR/75/ER)
Ali Khamesipour
Iranian journal of parasitology, 2014
View PDFchevron_right
Screening for Inhibitors of Essential Leishmania Glucose Transporters
Johanna Anderson
2013
View PDFchevron_right
Combination of Suboptimal Doses of Inhibitors Targeting Different Domains of LtrMDR1 Efficiently Overcomes Resistance of Leishmania spp. to Miltefosine by Inhibiting Drug Efflux
José Pérez-victoria
Antimicrobial Agents and Chemotherapy, 2006
View PDFchevron_right
Drug Resistance in Natural Isolates of Leishmania donovani s.l. Promastigotes Is Dependent of Pgp170 Expression
Vasiliki Christodoulou
PLoS ONE, 2013
View PDFchevron_right
Drug Resistance in Leishmaniasis
Shyam Sundar
Clinical Microbiology Reviews, 2006
View PDFchevron_right
Current Status of Existing and Emerging Chemotherapy and Drug Resistance Mechanisms in Leishmania
SONALI GANGWAR
International Journal of Advance Research and Innovative Ideas in Education, 2017
View PDFchevron_right
Putative P-Glycoprotein Expression in Arsenite-Resistant Leishmania donovani Down-Regulated by Verapamil
jaspreet kaur
Biochemical and Biophysical Research Communications, 2000
View PDFchevron_right
Biological Evaluation, Structure−Activity Relationships, and Three-Dimensional Quantitative Structure−Activity Relationship Studies of Dihydro-β-agarofuran Sesquiterpenes as Modulators of P-Glycoprotein-Dependent Multidrug Resistance
Carolina Pérez Reyes
Journal of Medicinal Chemistry, 2007
View PDFchevron_right
Drug Resistance in Visceral Leishmaniasis
Helena Maltezou
Journal of Biomedicine and Biotechnology, 2010
View PDFchevron_right
Changes in the infectivity, pyruvate kinase activity, acid phosphatase activity and P-glycoprotein expression in glibenclamide-resistant Leishmania mexicana
Alicia Ponte
Parasitology Research, 2000
View PDFchevron_right
Co-administration of glycyrrhizic acid with the antileishmanial drug sodium antimony gluconate (SAG) cures SAG-resistant visceral leishmaniasis
Amrita Bhattacharjee
International Journal of Antimicrobial Agents, 2015
View PDFchevron_right
Defeating Leishmania resistance to Miltefosine (hexadecylphosphocholine) by peptide-mediated drug smuggling: A proof of mechanism for trypanosomatid chemotherapy
Jean-mathieu Bart
Journal of Controlled Release, 2012
View PDFchevron_right
Drug resistance in leishmaniasis: current drug-delivery systems and future perspectives
Akhtar Nadhman
View PDFchevron_right
Sitamaquine Overcomes ABC-Mediated Resistance to Miltefosine and Antimony in Leishmania
José Pérez-victoria , Mercedes Campillo
Antimicrobial Agents and Chemotherapy, 2011
View PDFchevron_right
Combination of Suboptimal Doses of Inhibitors Targeting Different Domains of LtrMDR1 Efficiently Overcomes Resistance of Leishmania Spp. to Miltefosine by Inhibiting …
M. P . Costi
Antimicrobial agents …, 2006
View PDFchevron_right
Drug uptake and modulation of drug resistance in Leishmania by an aquaglyceroporin
Benjamin Gourbal
Journal of Biological …, 2004
View PDFchevron_right
High-Affinity Binding of Silybin Derivatives to the Nucleotide-Binding Domain of a Leishmania tropica P-Glycoprotein-Like Transporter and Chemosensitization of a Multidrug-Resistant Parasite to Daunomycin
José Pérez-victoria
Antimicrobial Agents and Chemotherapy, 2001
View PDFchevron_right
Inhibition of ABC Transporters Abolishes Antimony Resistance in Leishmania Infection
Krishna Pandey
Antimicrobial Agents and Chemotherapy, 2008
View PDFchevron_right